Dacarbazine (APP Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Dacarbazine drug offered from APP Pharmaceuticals, LLC. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: APP Pharmaceuticals, LLC
NON-PROPRIETARY NAME: DACARBAZINE
SUBSTANCE NAME: DACARBAZINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2001-09-07
END MARKETING DATE: 0000-00-00


Dacarbazine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDacarbazine from APP Pharmaceuticals, LLC
LABELER NAME: APP Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 2001-09-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-127_cee49be4-a9e3-4f9f-852e-a3d3b25ac44f
PRODUCT NDC: 63323-127
APPLICATION NUMBER: ANDA075371

Other DACARBAZINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCDacarbazine
Hospira Worldwide, Inc.Dacarbazine
Teva Parenteral Medicines, Inc.Dacarbazine